PhRMA Sues HHS in Bid to Repeal 340B Orphan Drug Rule

PhRMA has launched a lawsuit to shoot down a requirement that drugmakers provide orphan drugs to hospitals and healthcare providers at drastically reduced prices under the federal 340B discount drug program. Orphan drugs were previously exempt from the program.
Drug Industry Daily